Natures Sunshine Products Inc (NATR) stock
NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3057% below fair value
$10.18+0.01 (+0.10%)
Close on Nov 20, 2026Market cap $179.12MP/E 10.1Yield –
Natures Sunshine Products free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Natures Sunshine Products's free cash flow for the twelve months ending Jun 30, 2026 was $18.09M, down 19.1% year over year. For fiscal 2025 it was $28.84M, up 101.3% from the year before. The highest annual figure on record is $32.75M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.84M | +101.3% |
| FY2024 | Dec 31, 2024 | $14.33M | -53.4% |
| FY2023 | Dec 31, 2023 | $30.75M | – |
| FY2022 | Dec 31, 2022 | -$6.92M | -124.8% |
| FY2021 | Dec 31, 2021 | $27.94M | -14.7% |
| FY2020 | Dec 31, 2020 | $32.75M | +851.9% |
| FY2019 | Dec 31, 2019 | $3.44M | -79.8% |
| FY2018 | Dec 31, 2018 | $17.00M | +238.4% |
| FY2017 | Dec 31, 2017 | $5.02M | – |
| FY2016 | Dec 31, 2016 | -$7.61M | – |
| FY2015 | Dec 31, 2015 | -$12.37M | – |
| FY2014 | Dec 31, 2014 | -$12.10M | -158.2% |
| FY2013 | Dec 31, 2013 | $20.81M | +3.9% |
| FY2012 | Dec 31, 2012 | $20.02M | +1244.7% |
| FY2011 | Dec 31, 2011 | $1.49M | -89.0% |
| FY2010 | Dec 31, 2010 | $13.56M | – |
| FY2009 | Dec 31, 2009 | -$2.28M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.94M | -164.9% |
| Q1 FY2026 | Mar 31, 2026 | -$4.33M | -388.6% |
| Q4 FY2025 | Dec 31, 2025 | $7.56M | -24.3% |
| Q3 FY2025 | Sep 30, 2025 | $16.79M | +113.0% |
| Q2 FY2025 | Jun 30, 2025 | $2.99M | – |
| Q1 FY2025 | Mar 31, 2025 | $1.50M | – |
| Q4 FY2024 | Dec 31, 2024 | $9.99M | +19.6% |
| Q3 FY2024 | Sep 30, 2024 | $7.88M | -20.2% |
| Q2 FY2024 | Jun 30, 2024 | -$2.05M | -137.1% |
| Q1 FY2024 | Mar 31, 2024 | -$1.50M | -121.4% |
| Q4 FY2023 | Dec 31, 2023 | $8.35M | +1131.6% |
| Q3 FY2023 | Sep 30, 2023 | $9.88M | +79.5% |
| Q2 FY2023 | Jun 30, 2023 | $5.52M | – |
| Q1 FY2023 | Mar 31, 2023 | $7.00M | – |
| Q4 FY2022 | Dec 31, 2022 | $678.00K | -94.5% |
| Q3 FY2022 | Sep 30, 2022 | $5.50M | -29.8% |
| Q2 FY2022 | Jun 30, 2022 | -$3.66M | -160.3% |
| Q1 FY2022 | Mar 31, 2022 | -$9.44M | -638.9% |
| Q4 FY2021 | Dec 31, 2021 | $12.29M | +30.8% |
| Q3 FY2021 | Sep 30, 2021 | $7.84M | -29.7% |
| Q2 FY2021 | Jun 30, 2021 | $6.06M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.75M | -85.8% |
| Q4 FY2020 | Dec 31, 2020 | $9.39M | +290.8% |
| Q3 FY2020 | Sep 30, 2020 | $11.15M | +125.0% |
| Q2 FY2020 | Jun 30, 2020 | -$97.00K | -126.6% |
| Q1 FY2020 | Mar 31, 2020 | $12.31M | – |
| Q4 FY2019 | Dec 31, 2019 | $2.40M | -64.4% |
| Q3 FY2019 | Sep 30, 2019 | $4.96M | +42.4% |
| Q2 FY2019 | Jun 30, 2019 | $364.00K | -89.7% |
| Q1 FY2019 | Mar 31, 2019 | -$4.28M | -232.8% |
| Q4 FY2018 | Dec 31, 2018 | $6.75M | +670.9% |
| Q3 FY2018 | Sep 30, 2018 | $3.48M | -56.3% |
| Q2 FY2018 | Jun 30, 2018 | $3.54M | – |
| Q1 FY2018 | Mar 31, 2018 | $3.23M | – |
| Q4 FY2017 | Dec 31, 2017 | $876.00K | – |
| Q3 FY2017 | Sep 30, 2017 | $7.97M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.88M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.94M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.74M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.74M | – |
See a number that looks wrong?